Arrastra la portada para recortarla
@ianbell78
Me gusta
Sin Me Gusta
Pin
The global peptide therapeutics market was valued at USD 21.5 billion in 2016 and is expected to grow at a CAGR of 9.4% over the forecast period. Increasing prevalence of cancer and metabolic disorders such as osteoporosis, obesity, & diabetes are the key factors contributing toward the adoption of peptide therapeutics over the forecast period. The demand for efficient and low-cost drugs is very high due to the growing base of affected pediatric population and prevalence of target diseases in low-income countries.
Siguiendo
(22)
Seguidores
(6)
Recorta tu avatar
